Patients with Chronic Urticaria Remain Largely Undertreated: Results from the DERMLINE Online Survey

[11] Abuzakouk M(2017)H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought—first results of the multicenter real-life AWARE study Clin Exp Allergy 47 684-347

[12] Berard F(2012)Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients J Dtsch Dermatol Ges 10 341-1372 e1361-1366

[13] Barbosa F(2014)Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control J Allergy Clin Immunol. 133 1365-873

[14] Freitas J(2010)Epidemiology of urticaria: a representative cross-sectional population survey Clin Exp Dermatol 35 869-628

[15] Barbosa A(2011)Chronic urticaria Indian J Dermatol 56 622-584

[16] Staubach P(2018)Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data Allergy 73 576-506

[17] Dechene M(2019)European S2k guideline on chronic pruritus Acta Derm Venereol 99 469-180

[18] Metz M(2004)10 years experience of the Dermatology Life Quality Index (DLQI) J Investig Dermatol Symp Proc 9 169-39

[19] Staubach P(2008)Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients Arch Dermatol 144 35-160

[20] Eckhardt-Henn A(2015)Healthcare resource utilisation among chronic spontaneous/idiopathic urticaria patients—findings from the First International Burden of Illness Study (Assure-Csu) Value Health 18 A424-1069

[11] Abuzakouk M(2017)H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought—first results of the multicenter real-life AWARE study Clin Exp Allergy 47 684-347

[12] Berard F(2012)Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients J Dtsch Dermatol Ges 10 341-1372 e1361-1366

[13] Barbosa F(2014)Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control J Allergy Clin Immunol. 133 1365-873

[14] Freitas J(2010)Epidemiology of urticaria: a representative cross-sectional population survey Clin Exp Dermatol 35 869-628

[15] Barbosa A(2011)Chronic urticaria Indian J Dermatol 56 622-584

[16] Staubach P(2018)Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data Allergy 73 576-506

[17] Dechene M(2019)European S2k guideline on chronic pruritus Acta Derm Venereol 99 469-180

[18] Metz M(2004)10 years experience of the Dermatology Life Quality Index (DLQI) J Investig Dermatol Symp Proc 9 169-39

[19] Staubach P(2008)Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients Arch Dermatol 144 35-160

[20] Eckhardt-Henn A(2015)Healthcare resource utilisation among chronic spontaneous/idiopathic urticaria patients—findings from the First International Burden of Illness Study (Assure-Csu) Value Health 18 A424-1069